IDPC and MUCD provide an overview of the key models of regulation and offer general recommendations to improve public policies in areas where legislation is already in place and to improve decision-making in countries where reform is pending.
This paper provides recommendations for overcoming challenges in light of current policies and practices in Thailand so that the drug treatment system can result in improved health and human rights outcomes for people who use drugs and people dependant on drugs.
This year’s report, which includes content like interactive maps and data sets, is one of the agency’s most thorough and accessible publications to date.
IDPC and WACD summarise and review existing drug legislation from the 15 ECOWAS member states, as well as Mauritania and Morocco, concluding on the need for reform to align domestic laws with regional and international commitments.
In this advocacy note, IDPC offers some analysis and key recommendations on CBD and tramadol to inform the ECDD’s meeting set to take place in November 2017.
This IDPC progress report provides an overview of our activities between 2016 and 2017, including our continuing efforts to build capacity for drug policy advocacy and the numerous publications and resources produced during this period.
IDPC calls upon the OHCHR to promote harm reduction, reiterate its call for the decriminalisation of drug use and end all other forms of inhumane and disproportionate punishment.
In an effort to help digest and contextualise the UNGASS Outcome Document, this IDPC briefing paper explores a selection of key themes by analysing the consensus-based language agreed by UN member states during high-level meetings over the last quarter of a century.
IDPC analyses some key aspects of the INCB report, focusing on the Foreword, the thematic chapter on women and drugs and the INCB's approach towards health, human rights and cannabis regulation.
The English Harm Reduction Group have published a statement, strongly condemning the absence of harm reduction in the UK Drug Strategy, despite dramatically increasing numbers of drug-related deaths.
IDPC, WOLA, CIM and Dejusticia have published a series to share examples of innovative approaches that incorporate a gender perspective and the principles of public health and human rights into drug policy.
IDPC and PRI discuss how the UNGASS Outcome Document provides unprecedented opportunities to propose criminal justice reform and drug policy options grounded in fundamental UN principles.
IDPC, WOLA and CELS address the human rights implications of incarceration of women in their submission to the upcoming OHCHR report on over-incarceration.
